Immutep (IMMP) stock

Market cap $22.8M

$3.10

-3.12%

As of 7:28 PM ET after-hours, delayed 15+ min · Live for Pro members

Not scored

Breakaway doesn't score IMMP. It is too small and too thinly traded for a fair Quality Score.

Healthcare · Pharma

Follow IMMP's trial news. Pro members can get an alert when Immutep files news, and see its trials, share raises, and its CEO's filings.

Get an alert when IMMP files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

What's next for IMMP

Its trials

A trial underway: Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung CancerPhase 3 · Active · 756 people · main data estimated Jun 2027 · NCT06726265

For Pro members: 77 filings.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when Marc Voigt buys or sells

For Pro members: every trade, and Marc Voigt’s 7 filings and quotes.

Get an alert when IMMP files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 15 daysANDA decisionIn 15 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

IMMP's latest filings

Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement6-K, filed Oct 14
Change to American Depositary Share Ratio6-K, filed Sep 22
A new insider's holdings3, filed Apr 16

23 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why IMMP isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. IMMP is worth about $22.8M and trades about 20,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.